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FEMALE mice of the IF strain and its Flhybrids have been shown to give a
high yield of granulosa-celled tumours of the ovary, as well as breast tumours,
after skin paintings with an oily solution of 9: 10-dimethyl-1 : 2-benzanthracene
(DMBA) (Howell, Marchant and Orr, 1954). This carcinogen has since been
renamed 7, 12-dimethylbenz(a)anthracene.
In a subsequent experiment, which has beenpreliminarilyreported (Marchant,
1959a), it was shown thatreciprocal bilateral ovariangrafts made between normal
mice and mice treated with DMBA resulted in the development of tumours in
the majority of mice with ovaries grafted from treated mice, while treated mice
bearing grafts of normal ovaries developed only breast tumours.
Thepresent paperreports thisexperiment in more detail. It also extends it to
include the exchange of only one ovary between normal mice and mice treated
with DMBA to see whether the presence of normal ovarian tissue would inhibit
the development of tumours in ovaries from mice treated with the carcinogen.
MATERIALS AND METHOD
As in the previous experiment, the mice used were young adult virgin female
F, hybrids derived from C57BI mothers and IF fathers, and free from mammary
tumour agent. Half of them received fortnightly skin paintings of 0-5 per cent
DMBA in olive oil, about I mg. DMBA being given at each treatment. Six
paintings were given in all. After a further 2 or 3 weeks, both ovaries were
dissected from the ovarian capsules ofthe treated mice and from an equal number
of untreated mice. The mice were divided into 4 groups, 2 treated and 2 un-
treated. In the experiment already reported in brief, 2 groups were described
in which a bilateral reciprocal exchange of ovaries was made between treated and
untreated mice. In the other 2 groups of the present experiment, one ovary of
each treated and normal mouse was replaced and the other was reciprocally
exchanged. The ovaries were all grafted back inside ovarian capsules by the
technique described by Jones and Krohn (1960). The mice were housed 5 to a
box and fed on rat cubes known as the Thompson diet (Heygate and Sons) with
water ad lib. Vaginal smears were done on the mice at intervals. They were
kept until they died or their condition made it necessary to kill them. The
experiment was terminated 15 months after the grafting operation. At autopsy
breast tumours were noted. Ovaries were examined for tumours, then fixed,INHIBITION OF TUMOURS BY NORMAL OVARIAN TISSUE 515
sectioned and stained with haematoxylin and eosin. Ovaries not obviously
tumourous were serially sectioned and representative sections from different
levels examined for early tumours.
RESULTS
The numbers ofmice in the 4 groups which came to autopsy, with their survival
times and incidences of breast and ovarian tumours, are shown in Table 1.
TABLE I.-Breast and Ovarian Tumours Obtained After Unilateral or Bilateral
Exchange of Ovaries Between Carcinogen-Treated and Untreated Mice.
Number Number with ovarian tumours Mean
Grafted Number with breast survival
Hosts ovaries autopsied tumours Macroscopic Microscopic Cysts (months)
Normal 2 treated 18 0 13 1 7 14-4
Normal 1 treated 16 0 0 4 13 14-9
1 normal
Treated I treated 13 13 0 1 9 3-9
1 normal
Treated 2 normal 17 16 0 0 4 6.0
1. Normal hosts bearing bilateral grafts of ovariesfrom DMBA-treated mice
The 18 mice in this group survived between 10-3 and 15-3 months (mean 14-4
months) from the grafting operation.
None of the mice developed breast tumours. Near the time ofdeath, several
of them had fairly constant oestrus vaginal smears.
Ovarian grafts.-In 14 of the 18 mice solid ovarian tumours were found in one
of the grafted ovaries. Thirteen were macroscopic, most of them being I cm. or
more in diameter. Six of these 14 mice had large cysts filled with clear fluid in
the contralateral ovarian grafts. Of the 4 remaining mice, one had bilateral
cysts and the other had only atrophied remnants of ovarian tissue.
Histologically, I of the 14 tumours was a haemangioma. Five were typical granulosa-celled tumours. Five others were granulosa-celled tumours whose
cells showed varying degrees of luteinisation and the remaining 3 were almost
completely luteinised.
Oestrus or suboestrus vaginal smears were shown by the majority of the mice
with solid ovarian tumours, but not by those without.
2. Normal hosts bearing grafts of one normal ovary and one ovaryfrom a DMBA
treated mouse
The 16 mice in this group survived between 14 and 15 months from thegrafting operation (mean 14-9) months. The experiment was terminated at 15 months to
make this group comparable with the previous group. None of the mice developed breast tumours. Vaginal smears done near the
end of life were very variable, but few showed oestrus activity at that time.
(a) Grafts of ovariesfrom DMBA-treated mice.-In 4 of the' 16 mice, tumour
nodules were detected only after microscopical examination of the ovaries. One
was attached to a small cystfilledwith clearfluid and it was a luteinisedgranulosa-516 JUNE MARCHANT
celled tumour, as was I ofthe other nodules. Theremaining 2 very small nodules
ofgranulosa-celled tumour were not luteinised.
A further 7 grafts of ovaries from treated mice had developed into cysts filled
with clear fluid, varying in size, but ofthe order of I cm. diameter. Another one
had become a fibrinous clot. In the walls of the cysts, the only recognisable ova-
rian tissues remaining were heavily pigmented lutein cells and, occasionally,
hyalinised fragments of corpora lutea. Similar tissue was found in the remnants
of the other 4 ovaries grafted from DMBA-mice.
(b) Grafts of normal ovaries replaced in their hosts.-None of the normal
ovaries replaced in their normal hosts contained tumour nodules.
In 9 of the 16 animals, cysts filled with clear fluid arose, which were often I
cm. or more in diameter. In their walls, remnants of pigmented or hyalinised
lutein tissue were found. Four of these cysts were in mice which also had cysts
in their ovaries grafted from DMB-treated mice. The remaining 7 grafts were
atrophied and diffusely luteinised and 4 ofthem contained remnants ofhyalinised
corpora lutea. In 3 of the grafts a very few small follicles were found.
3. DMBA-treated hosts bearing grafts of one normal ovary and one ovary from a
DMBA-treated mouse
The 13 mice in this group survived between I and 5 months (mean 3-9 months)
from the grafting operation. The short survival time was due to the appearance
and rapid growth of breast tumours in all 13 mice. Nine of them developed
multiple breast tumours, 2 having as many as 5 tumours.
Histological examination of the tumours showed that they were adenocarcino-
mas, frequently of the papillary cystic type, with abundant fibroblastic stroma
andslight secretion. Squamousmetaplasia was notfrequently seen and sebaceous
metaplasia was only seen in one tumour.
Vaginal smears were again very variable, but with little evidence of oestrus
activity.
(a) Grafts of ovariesfrom DMBA-treated mice replaced in their host8.-In I of
the 13 DMBA-treated mice a nodule ofgranulosa-celled tumour was found in the
host's own replaced ovary. Clear fluid-filled cysts 0-5 to 1-0 cm. diameter with
pigmented cells in the cyst walls were found in 6 others. The remaining 6 grafts
were very atrophied and were composed of a few pigmented cells.
(b) Grafts of ovaries from normal mice.-No tumours developed in grafts of
ovaries from normal mice implanted in DMBA-treated hosts. In 5 animals they
developed into cysts filled with clear fluid. In the walls of the cysts normal
ovarian tissue, composed mainly of follicles and corpora lutea, was found. The
remaining 8 grafts of normal ovaries were similarly composed and they showed
slight atrophy.
4. DMBA-treated hosts bearing bilateral grafts of ovarie,3from normal mice
The 17 mice in this group survived 2
-5 to II months (mean 6months) from the
grafting operation. All except the mouse dying after 2-5 months developed
breast tumours, 7 of them having multiple tumours.
Histologically the breast tumours were adenocarcinomas, usuany with abund-
ant fibroblastic stroma and slight secretion. Foci of squamous metaplasia were
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Vaginal smears showed infrequent periods of oestrus. No tumours were
found in these mice.
Ovarian grafts.-In 4 of the 17 mice unilateral cysts were found. They were
0-5 to 1-0 cm. in diameter and filled with clear fluid. Follicles were present in
the cysts walls. The other ovarian grafts were somewhat atrophied but normal
ovarian structures werepresent inthem, namelyfollicles, corporalutea,pigmented
cells and, in some of the older grafts, hyaline corpora lutea characteristic of
C57BI/IF hybrids.
DISCUSSION
Of the 18 normal mice of group I bearing bilateral ovarian grafts from mice
treated with DMBA for 3 months, 14 (78 per cent) developed ovarian tumours,
13 being macroscopic. When treated ovaries were transplanted, a small pro-
portion ofthemprobably containedearly tumournodules. Apreviousexperiment
(Marchant, 1959b) in which DMBA-treated mice were killed at monthly intervals
showed the earliest detectable tumour nodule in 1 of 10 mice killed after 3 months,
after which there was a roughly linear increase in the proportion of mice with
tumours as time increased. It is certain that many of the 14 tumours in the
present experiment must have arisen from ovaries in which no detectable tumour
nodules were present at the time ofgrafting. The environment of the untreated
hosts whose own ovaries had been removed allowed the development of such
nodules and their growth to a large size.
The untreated mice of group 2 bearing grafts of one normal ovary and one
from a DMBA-treated animal survived a similar length of time to those of group
1. However, no macroscopic ovarian'tumours developed and microscopic tumour
nodules were found in only 4 ofthe 16 animals (25 per cent) in the ovaries grafted from treated mice. It is considered likely that these tumour nodules were all
present at the time of grafting, since a small proportion of animals previouslv killed after 3 months DMBA treatment had tumours (Marchant, 1959b). How-
ever the fact that no macroscopic tumours developed reveals the inhibitorv
influence of the normal ovaries grafted on the contralateral side.
Group 3 also shows this inhibitory effect. In the 13 DMBA treated animals
grafted with one normal ovary and one from a treated animal, only I microscopic
tumour nodule was found in an ovary from a treated animal. The survival of
this group of animals was 3-9 months from grafting and this should have been
ample time to yield a high proportion of tumours from the pretreated grafts if
no inhibitory factor had been present. The single microscopic tumour found had
probably been induced by the 3 months DMBA treatment prior to the time of
grafting.
The inhibition by normal ovarian tissue of tumour development in ovaries
grafted from mice pretreated with DMBA falls into line with the inhibition of
ovarian tumour development by other methods. For instance, after grafting an
ovary into the spleen of castrated rat tumours will appear in the grafts, but these
are prevented if one ovary is left intact (Biskind and Biskind, 1948). Similarly, the induction ofovarian tumours in mice afterX-ray treatment may beprevented by intact ovarian function (Li, Gardner and Kaplan, 1947 ; Lick, Kirschbaum
and Mixer, 1949 ; Kaplan, 1950). Exogenous oestrogen administration was also
found to inhibit ovarian tumourigenesis after intra-splenic grafting (Li and518 JUNE MARCHANT
Gardner, 1949) and after X-rays (Gardner, 1950). However, when stilboestrol
dipropionate was administered simultaneously with DMBA, it failed to inhibit
thedevelopment of ovarian tumours (Marchant, 1957). In this case the hormone
was administered along with the carcinogen by skin paintings of a mixture of the
two substances in olive oil. This method of administration may have been
ineffective because of different rates of assimilation of carcinogen and hormone,
the hormone probably being metabolised away more quickly than the carcinogen
on account oftheir differing solubilities.
SUMMARY
First generation hybrid mice from C57BI mothers and IF fathers were given
pretreatment of 6 fortnightly skin paintings of olive oil, each containing 1 mg.
of9:10-dimethyl-1:2-benzanthracene(DMBA). Bothoftheirovarieswerethen
reciprocally exchanged with those of similar untreated mice, or one ovary only
was exchanged and the other reimplanted. The grafts were made into the
ovarian capsules.
Ofthe 18 untreated mice with bilateralgrafts ofpretreated ovaries, 14 develo-
ped ovarian tumours, 13 being macroscopic. In the 16 untreated mice with
unilateral grafts of pretreated ovaries and contralateral normal ovaries, 4 micro-
scopic tumours were found in the grafts of pretreated ovaries. In 13 DMBA-
treated mice with similar unilateral grafts, only I microscopic ovarian tumour
was found in a pretreated ovary. The 17 DMBA-treated mice with bilateral
normal ovaries did not develop any ovarian tumours.
It is considered that the presence of the grafts of normal ovaries inhibited the
de-velopment of ovarian tumours in the mice -with unilateral grafts from mice
pretreated with DMBA. The small number of microscopic tumours found were
probably present at the time of ovarian grafting.
I am grateful to the Birmingham Branch of the British Empire Cancer Cam-
paign for support of this work.
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